BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Gross Profit 2019–2025
BridgeBio Pharma, Inc. annual/quarterly gross profit history and growth rate from 2021 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- BridgeBio Pharma, Inc. gross profit for the quarter ending March 31, 2026 was 184.6 M, a 61.92% increase year-over-year.
- BridgeBio Pharma, Inc. gross profit for the twelve months ending March 31, 2026 was 519.6 M, a 138.66% increase year-over-year.
- BridgeBio Pharma, Inc. annual gross profit for 2025 was 481.1 M, a 120.67% increase from 2024.
- BridgeBio Pharma, Inc. annual gross profit for 2024 was 218.0 M, a 3079.58% increase from 2023.
- BridgeBio Pharma, Inc. annual gross profit for 2023 was 6.9 M, a 90.76% decrease from 2022.
- BridgeBio Pharma, Inc. annual gross profit for 2022 was 74.2 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BridgeBio Pharma, Inc. Gross Profit — FAQ
BridgeBio Pharma, Inc. (BBIO) gross profit over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is BridgeBio Pharma, Inc.'s gross profit?
BridgeBio Pharma, Inc. (BBIO) reported gross profit of $481M for fiscal 2025.
Where can I see BBIO's gross profit history?
The chart and table above show BridgeBio Pharma, Inc.'s gross profit by year and by quarter, including the growth rate.